Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-09
DOI
10.1038/s41386-020-0667-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benzodiazepines or related drugs and risk of pneumonia: A systematic review and meta-analysis
- (2019) Guo-qing Sun et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Medicinal use of cannabis based products and cannabinoids
- (2019) Tom P Freeman et al. BMJ-British Medical Journal
- Parasitic pharmacology: A plausible mechanism of action for cannabidiol
- (2019) Geert Jan Groeneveld et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol Adverse Effects and Toxicity
- (2019) Marilyn A. Huestis et al. Current Neuropharmacology
- European drug agency approves cannabis-based medicine for severe forms of epilepsy
- (2019) Jacqui Wise BMJ-British Medical Journal
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer
- (2018) Melissa Badowski et al. Therapeutics and Clinical Risk Management
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- (2018) Simona Lattanzi et al. DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- The unexpected identification of the cannabimimetic, 5F-ADB, and dextromethorphan in commercially available cannabidiol e-liquids
- (2018) Justin L. Poklis et al. FORENSIC SCIENCE INTERNATIONAL
- Labeling Accuracy of Cannabidiol Extracts Sold Online
- (2017) Marcel O. Bonn-Miller et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits
- (2017) Benjamin K. Lau et al. NEUROPHARMACOLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
- (2016) Cathrin Rohleder et al. Frontiers in Pharmacology
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial
- (2013) Alin Andries et al. INTERNATIONAL JOURNAL OF EATING DISORDERS
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
- (2010) Celia JA Morgan et al. NEUROPSYCHOPHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid
- (2007) P. Massi et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now